DR REDDY S. LABORATORIES LTD SEZ

DR REDDY S. LABORATORIES LTD SEZ is a factory.

Company Introduction:

DR REDDY S. LABORATORIES LTD SEZ refers to a manufacturing facility or a unit operated by Dr. Reddy's Laboratories Ltd. within a Special Economic Zone (SEZ) in India. Dr. Reddy's Laboratories is a leading Indian multinational pharmaceutical company.

As a unit situated within an SEZ, this entity primarily focuses on the manufacturing, research, and development of pharmaceutical products, active pharmaceutical ingredients (APIs), and formulations. SEZs are designed to boost economic activity, and units within them often benefit from various tax incentives, simplified regulations, and robust infrastructure, particularly for export-oriented production.

This facility is integral to Dr. Reddy's global operations, contributing to the development and production of a diverse portfolio of medicines. These include generics, biosimilars, and proprietary products, catering to various therapeutic areas. The operations at this SEZ unit adhere to the stringent quality control and regulatory standards required by the global pharmaceutical industry.

Products Manufactured or Sold:

1. Active Pharmaceutical Ingredients (APIs)

These include a wide range of bulk drug substances used in the production of finished pharmaceutical formulations. The company produces various complex and specialty APIs, including those for oncology.

2. Generics (Finished Dosage Forms)

A comprehensive portfolio of generic medicines covering various therapeutic areas. These include products for:

Cardiovascular diseases

Diabetes management

Oncology

Gastroenterology

Pain management

Dermatology

Infectious diseases

Pediatrics

3. Branded Generics

Pharmaceutical products that are generic in composition but marketed under a specific brand name, primarily in emerging markets.

4. Biosimilars

Biologic medical products highly similar to an already approved biological medicine. Key biosimilars include those for oncology and autoimmune diseases, such as Rituximab, Pegfilgrastim, Darbepoetin alfa, and Filgrastim.

5. Over-the-Counter (OTC) Products

Non-prescription medicines for common ailments, including antacids, pain relievers, and cold and flu remedies.

6. Differentiated Products

Products that offer unique formulations, delivery systems, or other enhancements over standard generics, providing improved patient benefits.